📈 Revenue History (16 Quarters)
🧮 LXRX Revenue Breakdown
Understanding Revenue
Revenue, also called sales or the "top line," represents the total income a company generates from its business activities before any costs are deducted. For LXRX, the trailing twelve month revenue is $49.2M.
Why Revenue Matters
Revenue is the foundation of all financial analysis. A company cannot have sustainable profits without revenue, and revenue growth often drives stock price appreciation. However, revenue alone doesn't tell the full story - it must be analyzed alongside profitability metrics.
LXRX's revenue growth rate of 46.78% (based on log-linear regression of 16 quarters) indicates strong growth, typical of high-growth companies.
Revenue vs Profitability Metrics
Free Cash Flow: $-39.8M →
The cash remaining after capital expenditures. High revenue with negative FCF may indicate heavy reinvestment or poor cash conversion.
Owner Earnings: $-179.2M →
Buffett's metric for true cash generation. Compares revenue's conversion to actual owner value.
Earnings Per Share: $-0.15 →
Net income per share. The bottom line result of all revenue after costs, taxes, and interest.
Net Income: $-61.1M
What remains after all expenses. Net margin shows what percentage of revenue becomes profit.
Price/Sales Ratio Analysis
LXRX's P/S ratio of 20.4x means investors pay $20.36 for every $1 of annual revenue. A P/S above 10 indicates very high growth expectations.
Gross Margin: Revenue Quality
Gross margin of 99.43% shows how much of LXRX's revenue remains after direct costs. High gross margins above 60% often indicate strong pricing power, brand value, or intellectual property moats.
Summary: LXRX Revenue Trend
LEXICON PHARMACEUTICALS, INC. (LXRX) generated $49.2M in trailing twelve-month revenue, growing at 46.78% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses. LEXICON PHARMACEUTICALS, INC.'s gross margin of 99.43% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages. For complete financial analysis, view the full LXRX stock report on Zyberno.
Frequently Asked Questions
What is LXRX's current revenue?
LEXICON PHARMACEUTICALS, INC.'s trailing twelve month (TTM) revenue is $49.2M, growing at 46.78% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.
Is LXRX's revenue growing?
LEXICON PHARMACEUTICALS, INC. (LXRX) generated $49.2M in trailing twelve-month revenue, growing at 46.78% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses. LEXICON PHARMACEUTICALS, INC.'s gross margin of 99.43% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages.
What is LXRX's gross margin?
LEXICON PHARMACEUTICALS, INC.'s gross margin of 99.43% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages.
What is LXRX's Price/Sales ratio?
LXRX's P/S ratio is 20.4x, meaning the market values the company at 20.4 times its annual revenue.
How does revenue differ from profit?
Revenue is the total income before any expenses, while profit (net income) is what remains after all costs. LXRX's revenue is $49.2M with a net income of $-61.1M, showing a net profit margin of -124.1%.
📊 Full LXRX Stock Report →
See LXRX's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 LXRX Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 LXRX Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 LXRX Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 LXRX Earnings Surprise (SUE) →
See whether LXRX is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 LXRX Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 LXRX Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 LXRX Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 LXRX Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.